It’s interesting to watch how product and service development, and the marketing of these offerings, takes place in the group benefits industry. Products and services routinely seem to be developed based on perceived need and often don’t appear to have been thoroughly vetted by the end customer: plan sponsors. Once an offering is released into the market, there seems to be a subsequent rush of competitors looking to bring similar offerings to bear primarily to make sure they can check off the same capabilities boxes, as opposed to focusing on actual need and approach.
Health Minister Rona Ambrose has penned a sharply-worded letter calling for the provinces and territories to co-operate with the feds to help slash the cost of prescription drugs.
Moving to a publicly-funded, single-payer system for prescription drugs could save Canada billions of dollars, finds a study by The Mowat Centre.
Your employee has tried to treat her depression with at least two different medications but nothing seems to be working. She’s not alone: research suggests at least half of adults with major depressive disorder (MDD) will fail to respond to multiple attempts with antidepressants.
Teva Pharmaceutical Industries has made an unsolicited takeover offer to buy rival Mylan Pharmaceuticals for US$40 billion.
Valeant Pharmaceuticals International has completed the previously announced acquisition of Salix Pharmaceuticals.
Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals Inc. for about US$3.2 billion in a move to strengthen its position on central nervous system condition treatments.
Personalized medicine is coming to 22 B.C. pharmacies selected from across the province to participate in the first-of-its-kind study, Genomics for Precision Drug Therapy in the Community Pharmacy.
A national pharmacare program wouldn’t break the bank and should in fact save taxpayers billions of dollars, a new analysis suggests.
Canada’s Valeant Pharmaceuticals International has raised its bid to acquire Salix Pharmaceuticals for about US$11.1 billion ($14.2 billion).